ACCESS TO COMPREHENSIVE GENOMIC PROFILING INC (EIN 853497265) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

TOM FAGLEY

Phone

2025771370

Tax Period

2025-01-01 to 2025-12-31

ACCESS TO COMPREHENSIVE GENOMIC PROFILING INC, founded in 2020, is a small nonprofit in the Medical Research sector that reported $804K in total revenue in fiscal year 2025. Revenue grew 10% year-over-year, indicating healthy expansion. Expenses of $729K left a modest 9% surplus.

Mission

ACCESS TO COMPREHENSIVE GENOMIC PROFILING (ACGP) IS A COLLABORATIVE COALITION OF LEADING MOLECULAR DIAGNOSTICS COMPANIES AND LABORATORIES THAT AIMS TO RAISE AWARENESS ABOUT COMPREHENSIVE GENOMIC PROFILING (CGP) FOR ADVANCED CANCER PATIENTS. THE COALITION SEEKS TO EDUCATE STAKEHOLDERS ABOUT THE VALUE OF CGP TESTS IN ALL TUMOR TYPES, TO ASSURE APPROPRIATE USE IN THE PATIENT JOURNEY, TO INFORM MEDICAL MANAGEMENT AND IMPROVE CLINICAL OUTCOMES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $775,000

Program Service Revenue $0

Investment Income $28,675

Other Revenue $0

TOTAL REVENUE $803,675

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $475,961

Other Expenses $728,986

TOTAL EXPENSES $728,986

Year-over-Year Comparison

	2025	2024	Change
Revenue	$803,675	$729,547	+0.1%
Expenses	$728,986	$1,028,472	-0.3%
Net Income	$74,689	$-298,925	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SUZANNE BELINSON	CHAIR	1.00	Officer Director	$0	$0	$0
ROBERT DUMANOIS	VICE CHAIR	1.00	Officer Director	$0	$0	$0
TRAVIS ADAMS	VICE CHAIR	1.00	Officer Director	$0	$0	$0
DAWN CARDEIRO	TREASURER	1.00	Officer Director	$0	$0	$0
WILLIAM FUCICH	VICE CHAIR	1.00	Officer Director	$0	$0	$0
MARILY RHUDY	SECRETARY	1.00	Officer Director	$0	$0	$0
TOM FAGLEY	ASSISTANT TREASURER	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$803,675	$728,986	$767,119	$74,689
2024	No data	No data	No data	No data
2023	$973,164	$1,088,226	$991,355	$-115,062
2022	$895,000	$614,550	$1,106,417	$280,450

ACCESS TO COMPREHENSIVE GENOMIC PROFILING INC